Home › Markets › Health Care › NXL

Nexalin Technology Inc. (NXL)

NXL trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$2.64
-21.43% on the day
Market cap
$2.8M
Nano cap
Revenue · 2025
$302K
+78.8% on 2024
Net income · 2025
-$8.2M
-2725.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerNXL on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year2022
SEC CIK0001527352
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$302K
Net income-$8.2M
Operating income-$8.4M
Net margin-2725.8%
Operating margin-2781.7%
Revenue growth+78.8%
Cash$655K
Total assets$4.6M
P/E (computed)Net income was not positive
P/S (computed)9.2×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-1/A2026-10-08
Latest annual report10-K2026-03-25
Latest quarterly / interim10-Q2026-08-12
Latest current report8-K2026-10-01
Latest proxyDEF 14A2026-07-10

Source: SEC EDGAR submissions feed, 202 recent filings. All filings on EDGAR.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
VBIOValion Bio Inc.$1.55-7.74%$3.0M
NUWENuwellis Inc.$0.6210-7.36%$2.3M
NDRAENDRA Life Sciences Inc.$5.04-1.85%$7.6M
IRIXIRIDEX Corporation$0.8483-8.69%$14.9M
ITOCiTonic Holdings Ltd$3.94+10.06%$28.8M
QTIQT Imaging Holdings Inc.$2.45-5.77%$35.9M
POCIPrecision Optics Corporation Inc.$4.56-0.98%$50.0M
ECORelectroCore Inc.$8.39-9.59%$75.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier